Medication info
Rozetelpin Tablets 40/5/10/5 Milligrams

Rozetelpin Tablets 40/5/10/5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletRosuvastatin Calcium›5.2mg / 1 tabletEzetimibe›10mg / 1 tabletAmlodipine Besylate›6.944mg / 1 tablet
Manufacturer / importer
Green Cross Corporation
Appearance
Yellow oval film-coated tablets
Packaging
30 tablets/box [6 tablets/PTP X 5]
Approval status
Active

MFDS item code 202202188 · Approved 2022.05.23 · Insurance code 643606400

Summary

Main use
Treatment of dyslipidemia (including hypercholesterolemia) and essential hypertension
Who takes it
Adults
Adult dose
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Older adults: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. The dose may be increased to a maximum of 20/10mg daily. Patients taking the telmisartan/amlodipine combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Green Cross Corporation

Efficacy & effects

Treatment of dyslipidemia (including hypercholesterolemia) and essential hypertension

  • Hypertension
  • dyslipidemia
  • essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used when blood pressure is inadequately controlled in patients with essential hypertension who are taking combinations of telmisartan and amlodipine, as well as when additional control is needed in patients with dyslipidemia who are receiving combinations of rosuvastatin and ezetimibe. For hypertension treatment, it applies when blood pressure is not adequately controlled with monotherapy using amlodipine or telmisartan. For dyslipidemia, it helps to lower total cholesterol, LDL cholesterol, Apo B, triglycerides and non-HDL cholesterol levels, and raises HDL cholesterol levels, thus acting as an adjunct to dietary therapy. Consequently, this medication helps effectively improve the management of hypertension and dyslipidemia.

How to take

Adult dose

This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow this medicine whole; do not chew, divide, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of telmisartan should not exceed 40 mg. ◦ Older adults: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. For patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. The dose may be increased to a maximum of 20/10mg daily. Patients taking the telmisartan/amlodipine combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication can cause serious harm to the fetus if used during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Muscle-related side effects may occur rarely; consult a doctor if experiencing muscle pain or weakness. Patients allergic to any components of this medication or with severely impaired liver or kidney function should not take it. Patients with mildly impaired liver or kidney function should be cautious when using this medication and should have regular liver and kidney function tests. Patients with very low blood pressure, weak heart function, or certain heart diseases should also use this medication cautiously. As this medication may increase potassium levels in the blood, caution should be exercised when taking it with potassium supplements or medications rich in potassium. Dizziness or drowsiness may occur during treatment, so caution is needed when driving or operating machinery. If symptoms such as impaired liver function, muscle pain, or skin rash appear, inform a doctor immediately. This medication can interact with other drugs, so it is important to inform healthcare providers of all other medications being taken. Women of childbearing age using this medication should employ appropriate contraceptive methods to prevent pregnancy.

Side effects

Eyelid damage, head injury, urinary difficulty, flushing, chronic gastritis, various gastrointestinal disorders, hiatal hernia, facial edema, unusual sensations, drug intolerance, chest pain, irritable bowel syndrome, esophagitis, dizziness, drowsiness, neurodegenerative disorders, positional dizziness, migraine, diabetes, oral glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, sweating, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, breathing difficulties, pelvic pain, breast cysts, eyelid droop, diabetic retinopathy, ear discomfort, kidney dysfunction, benign esophageal neoplasm, upper respiratory infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, indigestion, abdominal bloating, vomiting, abdominal discomfort, dry mouth, abnormal liver function, liver disorders, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, asthenia, influenza-like illness, increased serum creatinine, increased serum uric acid, increased liver enzymes, elevated serum creatine kinase, decreased hemoglobin, angioedema, vasculitis, increased tension, sensory reduction, sensory abnormalities, peripheral neuropathy, taste disturbances, tremor, extrapyramidal disorder, erectile dysfunction, changes in bowel habits, gingival hypertrophy, pancreatitis, headache, facial spasms, sensory abnormalities, paralysis, hyperventilation, pneumonia, erectile dysfunction, edema, fatigue, weight gain, weight loss, insomnia, mood changes, hair loss, hyperhidrosis, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, petechiae, urticaria, hyperhidrosis, rash, itching, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, anaphylaxis, erythema multiforme, cholelithiasis, cholecystitis, tremors, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, cough, phlegm, rhinorrhea, limb pain, myalgia, arthralgia, diabetic neuropathy, upper abdominal pain, vomiting, gastritis, constipation, dry mouth syndrome, hepatitis, jaundice, elevated liver enzyme levels, thrombocytopenia, nausea, pancreatitis, amnesia, peripheral neuropathy, Stevens-Johnson syndrome, DRESS, interstitial pneumonia, thrombocytopenia, increased serum creatinine, oliguria, acute renal failure, syncope, generalized pain, muscle cramps, gout, chest discomfort, loss of appetite, abdominal bloating, weakness, edema, generalized edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Yellow oval film-coated tablets

Package unit

30 tablets/box [6 tablets/PTP X 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.